Critical appraisal:Sugi K, Nawata K, Fujita N, Ueda K, Tanaka T, Matsuoka T, et al 1998
From Cancer Guidelines Wiki
Critical Appraisal
Article being appraised
Sugi K, Nawata K, Fujita N, Ueda K, Tanaka T, Matsuoka T, et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg 1998 Mar;22(3):290-4; discussion 294-5 Available from: http://www.ncbi.nlm.nih.gov/pubmed/9494422.
Applicable clinical question
Key Facts
Study Design
randomised controlled trial
Number of Patients:
115
Includes an economic evaluation
no
Evidence ratings
Level of evidence
II
Risk of bias
| Moderate risk of bias | Comments: treatment assignment randomised, intention to treat analysis, good follow-up, but small numbers, not blinded. |
Size of effect
| 3 | Reason for decision: No difference between dissection and sampling |
Relevance of evidence
| 1 | Additional comments: Evidence of an effect on patient‐relevant clinical outcomes including survival. |
Result of appraisal
Included
Completed by
This appraisal has been completed.
- Article
- Sugi K, Nawata K, Fujita N, Ueda K, Tanaka T, Matsuoka T, et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg 1998 Mar;22(3):290-4; discussion 294-5 Available from: http://www.ncbi.nlm.nih.gov/pubmed/9494422.
- Assigned to
- User:Gavin.wright
- Topic area
- Guidelines:Lung cancer/Treatment/Non-small-cell stage I operable
- Clinical question
Section below only relevant for Cancer Council Project Officer